Tumor growth rate determines the timing of optimal chronomodulated treatment schedules

HIGHLIGHTS

• who: Samuel Bernard et al. from the Institute for Theoretical Biology, Humboldt University and Charité, Berlin, Germany, University of Lyon, Lyon, France, University Lyon, Faculty of Medicine Lyon Sud have published the research: Tumor Growth Rate Determines the Timing of Optimal Chronomodulated Treatment Schedules, in the Journal: (JOURNAL) of March/19,/2010
• what: The authors show that the duration of the phase of the cell cycle targeted by the treatment and the cell proliferation rate are crucial in determining the best times to administer CCS drugs. The authors show that the best and the worst . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.